Recent advances in the treatment of rheumatoid arthritis
Open Access
- 1 January 1999
- journal article
- review article
- Published by Elsevier in Clinical Cornerstone
- Vol. 2 (2) , 38-50
- https://doi.org/10.1016/s1098-3597(99)90013-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Guidelines for the management of rheumatoid arthritisArthritis & Rheumatism, 1996
- Reduction in long‐term disability in patients with rheumatoid arthritis by disease‐modifying antirheumatic drug–based treatment strategiesArthritis & Rheumatism, 1996
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritisThe Lancet, 1994
- Tumour necrosis factor: A specific trigger in arthritisResearch in Immunology, 1993
- The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalysesArthritis & Rheumatism, 1990
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARSThe Lancet, 1987